Pfizer Inc. (NYSE: PFE) shares closed slightly higher on Wednesday.
The New York-based pharmaceutical giant recently said that the European Commission approved PREVNAR 20, a caccine to help protect infants and children against pneumococcal disease.
On Jan. 30, Pfizer reported a surprise profit for the fourth quarter, with adjusted EPS of 10 cents versus a consensus loss of 22 cents. The company reported a 41% decline in sales to $14.25 billion, down from $24.3 billion a year ago.
Some investors may be eyeing potential gains from Pfizer’s dividends, too. The company currently offers an annual dividend yield of 5.95%, which is a quarterly dividend amount of 42 cents per share ($1.68 a year).
So, how can investors exploit its dividend yield to pocket a regular $500 monthly?
To earn $500 per month or $6,000 annually from dividends alone, you would need an investment of approximately…
